Show Summary Details
Page of

HIV/AIDS 

HIV/AIDS
Chapter:
HIV/AIDS
Author(s):

Graz A. Luzzi

, T.E.A. Peto

, P. Goulder

, and C. P. Conlon

DOI:
10.1093/med/9780199204854.003.070523_update_001

Update:

Epidemiology—updated HIV prevalence data and world distribution figure.

Diagnosis—new recommendations on HIV testing in higher prevalence areas.

Primary HIV infection—use of fourth-generation HIV tests; summary of results of the SPARTAC trial on antiretroviral treatment (ART) in primary HIV infection.

HIV and TB—new information on timing of initiation of ART in patients presenting with HIV-associated tuberculosis.

Primary cerebral lymphoma—updated section on treatment and prognosis.

Non-AIDS-defining cancers—new detailed section replaces former section on other tumours in AIDS.

HIV-associated nephropathy—detailed updating.

HIV/HCV coinfection—comment on new HCV protease inhibitors.

Management of HIV infection and prognosis—inclusion of new data on long-term prognosis; management of HIV-negative sexual partners.

Antiretroviral therapy—inclusion of new drugs;–updated recommendations on when to start ART and reference to the START study.

Bone metabolism—comment on osteoporosis, bone fracture risk, and contributing factors.

Prophylaxis of major opportunistic infections in HIV—table updated.

Prevention of HIV transmission—new discussion on risk of sexual transmission in patients on ART; updated information on vaginal microbicides and pre-exposure prophylaxis.

Updated on 31 May 2012. The previous version of this content can be found here.
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2015. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy).

date: 12 December 2017

Since its discovery in 1983, the human immunodeficiency virus (HIV) has been associated with a global pandemic that has affected more than 60 million people and caused more than 30 million deaths. The highest prevalence rates are in sub-Saharan Africa and other parts of the developing world. The impact of HIV in some African countries has been sufficient to reverse population growth and reduce life expectancy into the mid thirties, although HIV incidence has recently declined in some of these high-prevalence countries. However, there are large-scale epidemics of HIV elsewhere, e.g. India, the Russian Federation, and eastern Europe....

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.